Digital health – May 27, 2026
Skape Bio launches platform for AI-designed GPCR biotherapeutics
Skape Bio and researchers at the University of Washington’s Institute for Protein Design (IPD) have announced a peer-reviewed study published in Nature demonstrating a new way to design protein-based medicines for G protein-coupled receptors, or GPCRs.